Search Tag: Dr. Ingrid Delaet

Executive Health Management

2022 29 Sep

Neurocrine Biosciences, Inc.  announced that Dr. Ingrid Delaet will join the company's executive management team as Chief Regulatory Officer effective October 1, leading the regulatory affairs, quality assurance, medical writing, and program management teams. Dr. Delaet has served as Vice President of Regulatory Affairs at Neurocrine since January...Read more